Eltrombopag for Treatment of Thrombocytopenia After Hematopoietic Stem Cell Transplantation.

Creative Commons License

Güven Z. T., Çelik S., Eser B., Çetin M., Ünal A., Kaynar L.

Turkish journal of haematology : official journal of Turkish Society of Haematology, cilt.39, ss.103-108, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/tjh.galenos.2022.2021.0675
  • Dergi Adı: Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.103-108
  • Anahtar Kelimeler: Eltrombopag, Thrombocytopenia, Hematopoietic stem cell transplantation, Platelet recovery, VERSUS-HOST-DISEASE, PLATELET RECOVERY, SECONDARY FAILURE, THROMBOPOIETIN, EFFICACY, SAFETY
  • Erciyes Üniversitesi Adresli: Evet

Özet

Objective: This study aimed to evaluate the efficacy and safety of eltrombopag (ELT) in the treatment of thrombocytopenia following hematopoietic stem cell transplantation (HSCT).